FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Court Protects Drug Company Report Contents

[ Price : $8.95]

The Drug and Device Law Blog praises a recent federal court decision protecting some company corporate integrity agreement documen...

Tryptase Test System Special Controls Guidance

[ Price : $8.95]

FDA issues a special controls guideline to support classification of a tryptase test system into Class 2 (special controls).

Defending Failure to Instruct/Train Claims

[ Price : $8.95]

Attorneys John Lavelle and Jacqueline Gorbey say medical device companies should ensure that they provide technical support reques...

Guidance on ANDA Refuse-to-Receive Standards

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance: ANDA Submissions Refuse-to-Receive Standards.

Advisors Recommend New Testosterone Labeling

[ Price : $8.95]

FDA advisory committee members call for new language in testosterone labeling.

Teva Supports 180-Day Exclusivity Dispute Process

[ Price : $8.95]

Teva voices support for an FDA public process to address issues relating to 180-exclusivity.

FDA Releases Web Course on CMC Requirements for INDs

[ Price : $8.95]

FDA posts a new Web-based training course on Chemistry, Manufacturing, and Controls Perspective of the Investigational New Drug Ap...

Baxter Recalls 1 Lot of Mislabeled Potassium Chloride

[ Price : $8.95]

Baxter International recalls one lot of potassium chloride injection 10mEq per 100mL due to a labeling error on the shipping carto...

Transparency Has Gone Downhill at OGD: GPhA

[ Price : $8.95]

The Generic Pharmaceutical Association tells FDA that transparency has suffered since CDERs Office of Generic Drugs began operatin...

Sanofi, MyoKardia Collaborate on Cardiomyopathy Therapies

[ Price : $8.95]

Sanofi and MyoKardia announce their collaboration to discover and develop first-of-a-kind targeted therapeutics for heritable hear...